Promoting Adherence to Lymphedema Self-care

April 7, 2017 updated by: Sheila Ridner, Vanderbilt University

Promoting Adherence to Lymphedema Self-care in Breast Cancer Survivors

Lymphedema is a chronic condition that causes physical and emotional challenges to breast cancer survivors. As a progressive condition, lymphedema can result in swelling/fibrosis that can impair function, promote infection, and cause discomfort and emotional distress. Daily self-care that is required to manage lymphedema is time-consuming, burdensome, and lifelong. Previous studies found that about half of breast cancer survivors with lymphedema do not complete self-care as directed. Feelings of being helpless to manage the condition, a desire to be normal, lack of noticeable results from self-care, and poor social/healthcare professional support are barriers to performing self-care on a regular basis. There is a need to develop and test interventions to promote effective self-care. Experts suggest the best self-care interventions should include patient perspectives and be available a readily accessible format. Technological advancements support use of innovative, creative approaches, such as Web-based multimedia interventions. Web-based interventions can be used in rural and urban settings. The investigators are proposing to develop a Web-based, multimedia intervention and a "take home" manual to support self-care in breast cancer survivors with lymphedema. The investigators plan to conduct focus groups with these survivors to determine the content and delivery format(s) and to help us identify breast cancer survivors with lymphedema for the video component. The investigators will then develop an intervention that will include self-care demonstrations and other supportive information to help patients to cope with the challenges of self-care. The focus groups will reconvene, review the intervention, and give us feedback on modifying and refining the intervention. After finalizing the intervention, The investigators will recruit more breast cancer survivors with lymphedema and provide one half of them an education booklet and the other half the Web-based intervention (or an alternative format such as DVD). Then, over 12 months, the investigators will periodically assess and compare both groups on self-care behaviors, physical and emotional concerns, and other issues such as money spent on lymphedema treatment. The group that receives the education booklet will be given access to the Web-based intervention after the 12 month follow-up is done, but the investigators will not ask them to complete any more forms.

This project builds upon the investigators prior work that has provided information about lymphedema self-care problems and the investigators previous experience in developing patient education videos and manuals. By providing accessible, detailed self-care instructions and a psychosocial component, this intervention has the potential to improve lymphedema self-care. If successful, this intervention can be offered to the larger national and international community of breast cancer survivors with lymphedema.

Study Overview

Study Type

Interventional

Enrollment (Actual)

160

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Tennessee
      • Nashville, Tennessee, United States, 37072
        • Vanderbilt Univeristy School Of Nursing

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. have a history of breast cancer;
  2. previous diagnosis of lymphedema;
  3. Stage II lymphedema based upon International Society of Lymphedema (the limb is firm in places, elevation does not reduce swelling, it may or may not pit with pressure, and skin changes may be noted);
  4. be age 18 or older;
  5. be able to see and read printed documents in English; and for stage 2 only,
  6. have access to the Internet or a smart phone.

Exclusion Criteria: will not be:

  1. undergoing chemotherapy or radiation, or
  2. receiving hospice care. Additional exclusion criteria for local participants undergoing bioelectrical impedance measurements: pregnancy, metal implants, and defibrillator implants.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: web based multimedia intervention
interactive,web based multimedia intervention
cognitive therapy based web intervention
Active Comparator: education booklet
printed educational booklet
patient education booklet

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
symptom burden
Time Frame: change between baseline and 1, 3, 6, and 12 months post-intervention
self-report of symptoms will be documented on study instruments
change between baseline and 1, 3, 6, and 12 months post-intervention
function
Time Frame: change between baseline and 1, 3, 6, and 12 months post-intervention
Self-report functional data using a validated instrument
change between baseline and 1, 3, 6, and 12 months post-intervention
psychological well-being
Time Frame: change between baseline and 1, 3, 6, and 12 months post-intervention
self-report using a validated instrument
change between baseline and 1, 3, 6, and 12 months post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
coping
Time Frame: change between baseline and 1, 3, 6, and 12 months post-intervention
self-report using validated instrument
change between baseline and 1, 3, 6, and 12 months post-intervention
self-care activities
Time Frame: Change between baseline 1, 3, 6, and 12 months post-intervention
self report using a self-care checklist
Change between baseline 1, 3, 6, and 12 months post-intervention
stress
Time Frame: change between baseline and 1, 3, 6, and 12 months post-intervention
self-report using a validated instrument
change between baseline and 1, 3, 6, and 12 months post-intervention
self-efficacy
Time Frame: change between baseline and 1, 3, 6, and 12 months post-intervention
self-report using a validated instrument
change between baseline and 1, 3, 6, and 12 months post-intervention
social support
Time Frame: change between baseline and 1, 3, 6, and 12 months post-intervention
self-report using a validated instrument
change between baseline and 1, 3, 6, and 12 months post-intervention
extracellular fluid
Time Frame: change between baseline and 3, 6, and 12 months post-intervention
bioelectrical impedence measurement for sub set of participants
change between baseline and 3, 6, and 12 months post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

December 1, 2016

Study Completion (Actual)

December 1, 2016

Study Registration Dates

First Submitted

January 23, 2013

First Submitted That Met QC Criteria

January 25, 2013

First Posted (Estimate)

January 30, 2013

Study Record Updates

Last Update Posted (Actual)

April 10, 2017

Last Update Submitted That Met QC Criteria

April 7, 2017

Last Verified

April 1, 2017

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 124137-RSG-13-022-01-CPPB

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lymphedema Self-care

Clinical Trials on web based multimedia intervention

Subscribe